Alopecia Areata: Patches, Nail Changes, and the Variable Course

Alopecia areata is an autoimmune condition that causes non-scarring hair loss, often in smooth, round patches. The immune system disrupts hair production without destroying the follicle outright, so regrowth is possible. Its course is nevertheless unpredictable: hair may return, loss may recur, and some people develop more extensive disease.

It can appear at any age and affect the scalp, beard, eyebrows, eyelashes, or other body hair. A dermatologist should confirm the cause rather than assuming every round patch is alopecia areata.

What alopecia areata can look like

The most familiar presentation is one or more clearly defined, smooth areas of hair loss. The skin often looks otherwise fairly normal, without the heavy scale or crusting that would point toward another process. Some people notice tingling, itching, or sensitivity, but many have no physical symptoms beyond the hair change.

Short hairs that narrow toward the scalp, sometimes called exclamation-mark hairs, may be seen at the edge of an active patch. Other broken or regrowing hairs can also be present. These are examination clues, not features to use as a home diagnostic test.

Hair loss may remain limited to a small area or involve several sites. Its visible extent can change over time, and regrowth in one place does not rule out a new patch elsewhere.

Why the follicle remains important

A hair follicle is a living mini-organ that produces the visible hair shaft. In alopecia areata, immune activity around the follicle interferes with that production. Research describes disruption of the follicle’s normally protected immune environment, often called immune privilege, with cell-mediated immune responses playing a central role.

“Autoimmune” does not mean that a person caused the condition through a hairstyle or an ordinary week of stress. Genetics and environmental factors are both studied, but a single trigger cannot be established for every episode. Stress may be important to a person’s experience without being a proven sole explanation.

Non-scarring describes the preservation of follicular structure. It explains why regrowth can happen; it is not a promise that regrowth will be fast, complete, or permanent.

Patchy disease, totalis, universalis, and ophiasis

Clinicians use several terms to describe distribution:

  • Patchy alopecia areata: one or more localized areas of loss.
  • Alopecia totalis: complete or nearly complete loss of scalp hair.
  • Alopecia universalis: complete or nearly complete loss of hair across the scalp, face, and body.
  • Ophiasis: a band-like pattern around the sides and lower back of the scalp.

These labels describe extent and location. They do not, by themselves, tell an individual exactly what will happen next.

Nails and other clues

Some people also develop small pits, ridges, roughness, or other nail changes. Their presence can support the clinical picture, but many people with alopecia areata have unaffected nails. Nail changes also occur in other conditions, so they are not diagnostic on their own.

A clinician may ask about personal or family history of autoimmune conditions, previous episodes, body-hair involvement, recent illness, and medicines. These details help build context; they do not prove a particular trigger.

How a dermatologist distinguishes it from other patchy loss

The history, pattern, scalp surface, and hair shafts are examined together. Dermoscopy can reveal features too small to assess in a mirror. Depending on the presentation, testing for a fungal infection or a scalp biopsy may be considered.

This matters because tinea capitis, trichotillomania, traction, and scarring inflammatory conditions can also produce patches. Children with scaling, broken hairs, swollen lymph nodes, or inflamed areas need appropriate medical assessment rather than being presumed to have alopecia areata.

Documenting patches and regrowth

Consistent photographs can help distinguish a stable patch from one that is enlarging, and can show whether new loss is appearing elsewhere. Use similar lighting, distance, hair positioning, and styling each time rather than comparing unrelated close-ups. Include the date and note any nail or body-hair changes.

Short new hairs within a patch can be encouraging, but they do not establish that recovery will continue or that another patch will not develop. Likewise, a photograph cannot determine whether a smooth area is alopecia areata or another cause of loss. Bring the record to a dermatologist rather than using it to delay assessment of new, extensive, or changing disease.

If treatment is already underway, record what was actually used and when it changed rather than crediting the newest product for every later hair. Natural regrowth, treatment response, and recurrence can overlap in time. That record gives the clinician a clearer basis for continuing, adjusting, or pausing a plan.

The course is variable, not a fixed countdown

Limited patchy disease can regrow without treatment. New loss can appear while earlier patches recover, however, and some people experience repeated episodes over years. More extensive or long-standing disease can be less predictable. No calendar can guarantee an individual result.

Regrowing hair may initially look finer or lighter before its later appearance becomes clearer. A change in color or caliber during recovery is not a reliable forecast of the final outcome.

The emotional impact also deserves recognition. Anxiety, self-consciousness, and frustration are understandable responses, but they are not evidence that psychological distress caused the autoimmune process. Support and practical camouflage can sit alongside medical care.

What treatment is trying to do

Dermatologists tailor treatment to age, extent, duration, location, other health conditions, and patient priorities. Depending on the situation, options may include observation, topical or injected anti-inflammatory treatment, other immune-directed therapies, or prescription systemic medicines for more extensive disease.

Current systemic options have specific eligibility requirements, contraindications, and monitoring needs. A general article cannot determine those details or supply a safe individual regimen. Response varies, and relapse can occur after treatment is reduced or stopped.

Cosmetic measures—such as styling, hairpieces, brow or lash options, and scalp coverage—are legitimate ways to manage appearance. They do not alter the underlying immune condition, but neither are they a lesser or “failed” choice.

Frequently asked questions

Can alopecia areata regrow?

Yes, regrowth is possible because alopecia areata is non-scarring. Limited patches may recover without treatment, but timing and completeness vary, and loss can recur. More extensive or persistent disease may need dermatologist-managed treatment, and no outcome can be guaranteed.

Is alopecia areata contagious?

No. You cannot catch alopecia areata from another person or pass it on through ordinary contact. It is an autoimmune condition. A scalp infection can cause a different kind of patchy hair loss, which is one reason an uncertain patch should be assessed.

References

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases. Alopecia areata: symptoms, types, and causes. NIAMS overview.
  • DermNet. Alopecia areata: causes, clinical features, diagnosis, and management. Clinical overview.
  • Ito T. Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata. Clin Dev Immunol. 2013. DOI.
  • Kropidłowska J, et al. Comparison of current international guidelines for the management of alopecia areata. Int J Mol Sci. 2025;26:8632. DOI.
  • Robbins CR. Chemical and Physical Behavior of Human Hair. 5th ed. Springer; 2012. Book DOI.

About this article

Prepared by ANATOMY. This educational guide explains alopecia areata and its variable course without offering an individual diagnosis or prescription.

Evidence approach. NIAMS and DermNet informed the clinical overview; peer-reviewed literature and Robbins’ textbook informed mechanism and terminology. No personal medical review or product-treatment claim is made. Last updated October 30, 2026.